Cargando…

Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota

Non-alcoholic fatty liver disease (NAFLD) is a common liver disease with a rapidly increasing number of cases worldwide. This study aimed to evaluate the effects of Lactobacillus sakei MJM60958 (MJM60958) on NAFLD in vitro and in vivo. In in vitro tests, MJM60958 significantly inhibited lipid accumu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Huong Thi, Gu, Mingkun, Werlinger, Pia, Cho, Joo-Hyung, Cheng, Jinhua, Suh, Joo-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658623/
https://www.ncbi.nlm.nih.gov/pubmed/36362221
http://dx.doi.org/10.3390/ijms232113436
_version_ 1784829997148536832
author Nguyen, Huong Thi
Gu, Mingkun
Werlinger, Pia
Cho, Joo-Hyung
Cheng, Jinhua
Suh, Joo-Won
author_facet Nguyen, Huong Thi
Gu, Mingkun
Werlinger, Pia
Cho, Joo-Hyung
Cheng, Jinhua
Suh, Joo-Won
author_sort Nguyen, Huong Thi
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) is a common liver disease with a rapidly increasing number of cases worldwide. This study aimed to evaluate the effects of Lactobacillus sakei MJM60958 (MJM60958) on NAFLD in vitro and in vivo. In in vitro tests, MJM60958 significantly inhibited lipid accumulation by 46.79% in HepG2 cells stimulated with oleic acid and cholesterol (OA-C). Moreover, MJM60958 showed safe and probiotic characteristics in vitro. In the animal study, MJM60958 administration in a high-fat diet-induced NAFLD mouse model significantly reduced body weight and liver weight, and controlled aspartate aminotransferase (ALT), aspartate transaminase (AST), triglyceride (TG), urea nitrogen (BUN), and uric acid (UA) levels in the blood, which are features of NAFLD. Further, treatment with MJM60958 also reduced steatosis scores in liver tissues, serum leptin and interleukin, and increased serum adiponectin content. Moreover, administration of MJM60958 resulted in a significantly decreased expression of some genes and proteins which are related to lipid accumulation, such as fatty acid synthase (FAS), acetyl-CoA carboxylase (ACC), and sterol regulatory element-binding protein 1 (SREBP-1), and also upregulated genes and protein expression of lipid oxidation such as peroxisome proliferator-activated receptor alpha (PPARα) and carnitine palmitoyltransferase 1a (CPT1A). Administration of MJM60958 increased the relative abundance of specific microbial taxa such as Verrucomicrobia, which are abundant in non-NAFLD mice, and reduced Firmicutes, which are a major group in NAFLD mice. MJM60958 affected the modulation of gut microbiota and altered the strain profile of short-chain fatty acids (SCFAs) production in the cecum by reduced lactic acid and enhanced acetic acid production. Overall, MJM60958 showed potential as a probiotic that can prevent and treat NAFLD.
format Online
Article
Text
id pubmed-9658623
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96586232022-11-15 Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota Nguyen, Huong Thi Gu, Mingkun Werlinger, Pia Cho, Joo-Hyung Cheng, Jinhua Suh, Joo-Won Int J Mol Sci Article Non-alcoholic fatty liver disease (NAFLD) is a common liver disease with a rapidly increasing number of cases worldwide. This study aimed to evaluate the effects of Lactobacillus sakei MJM60958 (MJM60958) on NAFLD in vitro and in vivo. In in vitro tests, MJM60958 significantly inhibited lipid accumulation by 46.79% in HepG2 cells stimulated with oleic acid and cholesterol (OA-C). Moreover, MJM60958 showed safe and probiotic characteristics in vitro. In the animal study, MJM60958 administration in a high-fat diet-induced NAFLD mouse model significantly reduced body weight and liver weight, and controlled aspartate aminotransferase (ALT), aspartate transaminase (AST), triglyceride (TG), urea nitrogen (BUN), and uric acid (UA) levels in the blood, which are features of NAFLD. Further, treatment with MJM60958 also reduced steatosis scores in liver tissues, serum leptin and interleukin, and increased serum adiponectin content. Moreover, administration of MJM60958 resulted in a significantly decreased expression of some genes and proteins which are related to lipid accumulation, such as fatty acid synthase (FAS), acetyl-CoA carboxylase (ACC), and sterol regulatory element-binding protein 1 (SREBP-1), and also upregulated genes and protein expression of lipid oxidation such as peroxisome proliferator-activated receptor alpha (PPARα) and carnitine palmitoyltransferase 1a (CPT1A). Administration of MJM60958 increased the relative abundance of specific microbial taxa such as Verrucomicrobia, which are abundant in non-NAFLD mice, and reduced Firmicutes, which are a major group in NAFLD mice. MJM60958 affected the modulation of gut microbiota and altered the strain profile of short-chain fatty acids (SCFAs) production in the cecum by reduced lactic acid and enhanced acetic acid production. Overall, MJM60958 showed potential as a probiotic that can prevent and treat NAFLD. MDPI 2022-11-03 /pmc/articles/PMC9658623/ /pubmed/36362221 http://dx.doi.org/10.3390/ijms232113436 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nguyen, Huong Thi
Gu, Mingkun
Werlinger, Pia
Cho, Joo-Hyung
Cheng, Jinhua
Suh, Joo-Won
Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota
title Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota
title_full Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota
title_fullStr Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota
title_full_unstemmed Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota
title_short Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota
title_sort lactobacillus sakei mjm60958 as a potential probiotic alleviated non-alcoholic fatty liver disease in mice fed a high-fat diet by modulating lipid metabolism, inflammation, and gut microbiota
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658623/
https://www.ncbi.nlm.nih.gov/pubmed/36362221
http://dx.doi.org/10.3390/ijms232113436
work_keys_str_mv AT nguyenhuongthi lactobacillussakeimjm60958asapotentialprobioticalleviatednonalcoholicfattyliverdiseaseinmicefedahighfatdietbymodulatinglipidmetabolisminflammationandgutmicrobiota
AT gumingkun lactobacillussakeimjm60958asapotentialprobioticalleviatednonalcoholicfattyliverdiseaseinmicefedahighfatdietbymodulatinglipidmetabolisminflammationandgutmicrobiota
AT werlingerpia lactobacillussakeimjm60958asapotentialprobioticalleviatednonalcoholicfattyliverdiseaseinmicefedahighfatdietbymodulatinglipidmetabolisminflammationandgutmicrobiota
AT chojoohyung lactobacillussakeimjm60958asapotentialprobioticalleviatednonalcoholicfattyliverdiseaseinmicefedahighfatdietbymodulatinglipidmetabolisminflammationandgutmicrobiota
AT chengjinhua lactobacillussakeimjm60958asapotentialprobioticalleviatednonalcoholicfattyliverdiseaseinmicefedahighfatdietbymodulatinglipidmetabolisminflammationandgutmicrobiota
AT suhjoowon lactobacillussakeimjm60958asapotentialprobioticalleviatednonalcoholicfattyliverdiseaseinmicefedahighfatdietbymodulatinglipidmetabolisminflammationandgutmicrobiota